Kane Biotech Stock Price Prediction
| KNBIF Stock | USD 0.03 0 5.78% |
Momentum 62
Buy Extended
Oversold | Overbought |
Using Kane Biotech hype-based prediction, you can estimate the value of Kane Biotech from the perspective of Kane Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Kane Biotech to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Kane because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Kane Biotech after-hype prediction price | USD 0.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kane |
Kane Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Kane Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kane Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Kane Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kane Biotech Estimiated After-Hype Price Volatility
In the context of predicting Kane Biotech's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kane Biotech's historical news coverage. Kane Biotech's after-hype downside and upside margins for the prediction period are 0.00 and 5.60, respectively. We have considered Kane Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kane Biotech is out of control at this time. Analysis and calculation of next after-hype price of Kane Biotech is based on 3 months time horizon.
Kane Biotech Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Kane Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kane Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kane Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 5.57 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.03 | 0.03 | 3.23 |
|
Kane Biotech Hype Timeline
Kane Biotech is now traded for 0.03. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kane is forecasted to decline in value after the next headline, with the price expected to drop to 0.03. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -3.23%, whereas the daily expected return is now at 0.26%. The volatility of related hype on Kane Biotech is about 0.0%, with the expected price after the next announcement by competition of 0.03. About 27.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Kane Biotech last dividend was issued on the 13th of March 2017. The entity had 1:5 split on the 13th of March 2017. Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Kane Biotech Basic Forecasting Models to cross-verify your projections.Kane Biotech Related Hype Analysis
Having access to credible news sources related to Kane Biotech's direct competition is more important than ever and may enhance your ability to predict Kane Biotech's future price movements. Getting to know how Kane Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kane Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BIXT | Bioxytran | 0.00 | 0 per month | 5.61 | 0.06 | 13.09 | (11.37) | 39.72 | |
| MYNDF | MYND Lifesciencs | 0.00 | 0 per month | 0.00 | (0.02) | 0.00 | 0.00 | 113.60 | |
| BZYR | Burzynski Research | 0.00 | 0 per month | 12.21 | 0.04 | 23.68 | (23.81) | 134.21 | |
| TXTM | Protext Mobility | 0.00 | 0 per month | 4.86 | 0.12 | 16.13 | (8.33) | 32.26 | |
| FAMDF | Futura Medical plc | 0.00 | 0 per month | 27.29 | 0.19 | 100.00 | (50.00) | 480.00 | |
| BVAXF | Biovaxys Technology Corp | 0.00 | 0 per month | 5.92 | 0.05 | 12.50 | (10.00) | 42.22 | |
| GLWLF | Glow Lifetech Corp | 0.00 | 0 per month | 0.00 | 0.04 | 5.25 | (2.70) | 27.60 | |
| THER | Therasense | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PMEDF | Predictmedix | 0.00 | 0 per month | 6.29 | 0.08 | 18.00 | (13.33) | 139.39 | |
| BUDZ | Weed Inc | 0.00 | 0 per month | 8.76 | 0.04 | 20.47 | (16.50) | 52.70 |
Kane Biotech Additional Predictive Modules
Most predictive techniques to examine Kane price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kane using various technical indicators. When you analyze Kane charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Kane Biotech Predictive Indicators
The successful prediction of Kane Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kane Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kane Biotech based on analysis of Kane Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kane Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kane Biotech's related companies.
Currently Active Assets on Macroaxis
Complementary Tools for Kane Pink Sheet analysis
When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |